Lung Cancer
Volume 55, Issue 1 , Pages 75-78, January 2007

FDG-PET maximum standardised uptake value is associated with variation in survival: Analysis of 498 lung cancer patients

  • Andrew Davies

      Affiliations

    • The Thoracic Unit, Guy's Hospital, London SE1 9RT, United Kingdom
    • ,
  • Carol Tan

      Affiliations

    • The Thoracic Unit, Guy's Hospital, London SE1 9RT, United Kingdom
    • ,
  • Christos Paschalides

      Affiliations

    • Clinical Operational Research Unit, UCL, London, United Kingdom
    • ,
  • Sally F. Barrington

      Affiliations

    • PET Imaging Centre, St. Thomas’ Hospital, London, United Kingdom
    • ,
  • Mike O’Doherty

      Affiliations

    • PET Imaging Centre, St. Thomas’ Hospital, London, United Kingdom
    • ,
  • Martin Utley

      Affiliations

    • Clinical Operational Research Unit, UCL, London, United Kingdom
    • ,
  • Tom Treasure

      Affiliations

    • The Thoracic Unit, Guy's Hospital, London SE1 9RT, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 79 57 16 87 54; fax: +44 20 77 01 87 37.

Received 4 July 2006; received in revised form 13 September 2006; accepted 18 September 2006.

Summary 

We sought to establish the extent to which tumour uptake of [18F]-fluoro2-deoxy-glucose is associated with survival in patients with primary lung cancer. From our analysis of data concerning 498 lung cancer patients, including surgical and non-surgical cases, we conclude that there is a clear association between higher tumour uptake of glucose and worse survival.

Keywords: Lung cancer, Imaging, PET, SUV, Prognosis, Survival

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0169-5002(06)00489-2

doi:10.1016/j.lungcan.2006.09.010

Lung Cancer
Volume 55, Issue 1 , Pages 75-78, January 2007

Article Tools

* Image Usage & Resolution